NYRADA INC (ASX:NYR) 54 17. Share-based payments With the exception of 800,000 options which expired during the year, the number of options and performance shares representing amounts in the share-based payments reserve did not change (total of 48,700,000 options and 18,000,000 performance shares). The vesting charge taken to the profit and loss in-respect of these options and shares for the year was $541,214 and the transfer of fair value on expired options was ($80,240). Details of the fair value assumptions underpinning these share-based payment arrangements are disclosed in previous years' financial reports of the Company. The weighted average exercise price at the end of the financial year was $0.21 (2022: $0.21). The weighted average remaining contractual life of options and performance shares outstanding at the end of the financial year was 1.75 years (2022: 2.75 years). 18. Loss per share 2023 2022 $ $ Loss after income tax attributable to the owners of Nyrada Inc. (7,781,692) (3,959,661) Number Number Weighted average number of ordinary shares used in calculating basic earnings per share 156,008,700 156,008,700 Weighted average number of ordinary shares used in calculating diluted earnings per share 156,008,700 156,008,700 $ $ Basic loss per share (0.05) (0.03) Diluted loss per share (0.05) (0.03) There are 38,000,000 options which have vested and are considered to be dilutive. The options are not included as the Consolidated Entity is loss-making, so incorporating in the impacts of contingent equity is anti-dilutive. 19. Key Management Personnel disclosures Compensation The aggregate compensation made to directors and other members of Key Management Personnel of the Consolidated Entity is set out below: 2023 2022 $ $ Short-term employee benefits 926,321 864,908 Post-employment benefits 32,204 27,375 Share-based payments 245,547 570,297 1,204,072 1,462,580
RkJQdWJsaXNoZXIy MjE2NDg3